Verdence Capital Advisors LLC Novartis Ag Transaction History

Verdence Capital Advisors LLC

$1.23 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $855,847 - $996,468	-10,629 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $21,389 - $24,195	267 Added 2.58%	10,629 $933,000
Q4 2021 Jan 26, 2022	BUY	$79.7 - $88.13 $34,749 - $38,424	436 Added 4.39%	10,362 $906,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $20,608 - $23,975	252 Added 2.6%	9,926 $812,000
Q2 2021 Aug 06, 2021	BUY	$85.24 - $94.15 $36,397 - $40,202	427 Added 4.62%	9,674 $883,000
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $353,956 - $417,414	-4,239 Reduced 31.43%	9,247 $790,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $208,837 - $252,600	-2,675 Reduced 16.55%	13,486 $1.27 Million
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $201,160 - $222,859	-2,449 Reduced 13.16%	16,161 $1.41 Million
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $43,459 - $48,920	537 Added 2.97%	18,610 $1.63 Million
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $208,688 - $292,376	2,953 Added 19.53%	18,073 $1.49 Million
Q4 2019 Feb 03, 2020	BUY	$84.35 - $95.37 $759 - $858	9 Added 0.06%	15,120 $1.43 Million
Q3 2019 Mar 06, 2020	BUY	$85.54 - $94.26 $8,126 - $8,954	95 Added 0.63%	15,111 $1.31 Million
Q2 2019 Mar 02, 2020	BUY	$75.4 - $92.8 $60,621 - $74,611	804 Added 5.66%	15,016 $1.37 Million
Q1 2019 Mar 02, 2020	BUY	$75.32 - $86.15 $23,801 - $27,223	316 Added 2.27%	14,212 $1.37 Million
Q4 2018 Feb 25, 2020	BUY	$73.66 - $82.02 $171,996 - $191,516	2,335 Added 20.2%	13,896 $1.19 Million
Q3 2018 Feb 25, 2020	SELL	$66.94 - $77.43 $26,575 - $30,739	-397 Reduced 3.32%	11,561 $996,000
Q2 2018 Feb 11, 2020	SELL	$64.91 - $73.36 $46,929 - $53,039	-723 Reduced 5.7%	11,958 $903,000
Q1 2018 Jan 30, 2020	BUY	$70.39 - $84.15 $122,830 - $146,841	1,745 Added 15.96%	12,681 $1.03 Million
Q4 2017 Jan 30, 2020	BUY	$72.33 - $77.64 $791,000 - $849,071	10,936	10,936 $918,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account